Loading…

Carbamazepine-resistance in the epileptic dentate gyrus of human hippocampal slices

Overexpression of drug efflux pumps at the blood brain barrier (BBB) has been suggested to be one important factor contributing to drug resistance in epilepsy. This would imply that resected brain tissue of drug-resistant patients is drug-sensitive in absence of the BBB. Here we studied the effects...

Full description

Saved in:
Bibliographic Details
Published in:Brain (London, England : 1878) England : 1878), 2006-12, Vol.129 (12), p.3290-3306
Main Authors: Jandová, Katerina, Päsler, Dennis, Antonio, Leandro Leite, Raue, Claudia, Ji, Shengbo, Njunting, Marleisje, Kann, Oliver, Kovács, Richard, Meencke, Heinz-Joachim, Cavalheiro, Esper A., Heinemann, Uwe, Gabriel, Siegrun, Lehmann, Thomas-Nicolas
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c453t-d4e14389a3e2960204787bcd5d12640f3664691d9729e03b4ce27652f1657c833
cites
container_end_page 3306
container_issue 12
container_start_page 3290
container_title Brain (London, England : 1878)
container_volume 129
creator Jandová, Katerina
Päsler, Dennis
Antonio, Leandro Leite
Raue, Claudia
Ji, Shengbo
Njunting, Marleisje
Kann, Oliver
Kovács, Richard
Meencke, Heinz-Joachim
Cavalheiro, Esper A.
Heinemann, Uwe
Gabriel, Siegrun
Lehmann, Thomas-Nicolas
description Overexpression of drug efflux pumps at the blood brain barrier (BBB) has been suggested to be one important factor contributing to drug resistance in epilepsy. This would imply that resected brain tissue of drug-resistant patients is drug-sensitive in absence of the BBB. Here we studied the effects of carbamazepine (CBZ) at therapeutically relevant concentration on epileptiform activity electrophysiologically recorded in acute hippocampal slices of patients with mesial temporal lobe epilepsy (MTLE; 28 patients, 49 slices) or extra-hippocampal tumours (tumour; 6 patients, 11 slices). Epileptiform activity was induced by hilar stimulation (0.067 Hz) during elevation of extracellular potassium concentration ([K+]o) and remained self-sustained in presence of 10–12 mM [K+]o. Quantitative analysis of data revealed that epileptiform activity in tissue of tumour-patients was predominantly suppressed by CBZ, indicating that the ‘epilepsy model’ used is CBZ-sensitive. In contrast, epileptiform activity in tissue of drug-resistant MTLE patients was resistant to CBZ in 82% of patients, partially suppressed in 11% and completely suppressed in 7%. The effects of CBZ in tissue of MTLE patients did not depend on the type of activity, hippocampal pathology, excitability of the tissue, or equilibration time of the drug. Considering that CBZ has direct access to all compartments of the slice, our results suggest that CBZ-resistance mechanisms are located within the parenchyma of the dentate gyrus and contribute to drug resistance in the majority of MTLE patients. BBB-located drug-resistance mechanisms per se may play a minor role in this region, because CBZ-sensitivity was only observed in 7% of CBZ-resistant patients.
doi_str_mv 10.1093/brain/awl218
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68196142</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68196142</sourcerecordid><originalsourceid>FETCH-LOGICAL-c453t-d4e14389a3e2960204787bcd5d12640f3664691d9729e03b4ce27652f1657c833</originalsourceid><addsrcrecordid>eNqF0ctrFTEUB-AgFntb3bmWINiVY_M8M1mWS2vF-sIHxU3IZM54U-dlMkOtf72p92LBjatA8nFyzvkR8pizF5wZeVxHF4Zjd90JXt0jK66AFYJruE9WjDEoKqPZPjlI6YoxrqSAB2Sfg9FccbYiH9cu1q53v3AKAxYRU0izGzzSMNB5gzTfdzjNwdMGh9nNSL_dxCXRsaWbpXcD3YRpGr3rJ9fR1AWP6SHZa12X8NHuPCSfz04_rc-Li3cvX61PLgqvtJyLRmHupzJOojDABFNlVda-0Q0XoFgrARQY3phSGGSyVh5FCVq0HHTpKykPydG27hTHHwum2fYheew6N-C4JAsVN8CV-C_keUVMQ5nh03_g1bjEIQ9xa5TKv7OMnm-Rj2NKEVs7xdC7eGM5s7eR2D-R2G0kmT_Z1VzqHps7vMsgg2c74JJ3XRvz-kO6c5UEBgKyK7YuJ4Q__767-N3m1kttzy-_Wrgs3795--W1_SB_A1kto2U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>195446520</pqid></control><display><type>article</type><title>Carbamazepine-resistance in the epileptic dentate gyrus of human hippocampal slices</title><source>Oxford Journals Online</source><creator>Jandová, Katerina ; Päsler, Dennis ; Antonio, Leandro Leite ; Raue, Claudia ; Ji, Shengbo ; Njunting, Marleisje ; Kann, Oliver ; Kovács, Richard ; Meencke, Heinz-Joachim ; Cavalheiro, Esper A. ; Heinemann, Uwe ; Gabriel, Siegrun ; Lehmann, Thomas-Nicolas</creator><creatorcontrib>Jandová, Katerina ; Päsler, Dennis ; Antonio, Leandro Leite ; Raue, Claudia ; Ji, Shengbo ; Njunting, Marleisje ; Kann, Oliver ; Kovács, Richard ; Meencke, Heinz-Joachim ; Cavalheiro, Esper A. ; Heinemann, Uwe ; Gabriel, Siegrun ; Lehmann, Thomas-Nicolas</creatorcontrib><description>Overexpression of drug efflux pumps at the blood brain barrier (BBB) has been suggested to be one important factor contributing to drug resistance in epilepsy. This would imply that resected brain tissue of drug-resistant patients is drug-sensitive in absence of the BBB. Here we studied the effects of carbamazepine (CBZ) at therapeutically relevant concentration on epileptiform activity electrophysiologically recorded in acute hippocampal slices of patients with mesial temporal lobe epilepsy (MTLE; 28 patients, 49 slices) or extra-hippocampal tumours (tumour; 6 patients, 11 slices). Epileptiform activity was induced by hilar stimulation (0.067 Hz) during elevation of extracellular potassium concentration ([K+]o) and remained self-sustained in presence of 10–12 mM [K+]o. Quantitative analysis of data revealed that epileptiform activity in tissue of tumour-patients was predominantly suppressed by CBZ, indicating that the ‘epilepsy model’ used is CBZ-sensitive. In contrast, epileptiform activity in tissue of drug-resistant MTLE patients was resistant to CBZ in 82% of patients, partially suppressed in 11% and completely suppressed in 7%. The effects of CBZ in tissue of MTLE patients did not depend on the type of activity, hippocampal pathology, excitability of the tissue, or equilibration time of the drug. Considering that CBZ has direct access to all compartments of the slice, our results suggest that CBZ-resistance mechanisms are located within the parenchyma of the dentate gyrus and contribute to drug resistance in the majority of MTLE patients. BBB-located drug-resistance mechanisms per se may play a minor role in this region, because CBZ-sensitivity was only observed in 7% of CBZ-resistant patients.</description><identifier>ISSN: 0006-8950</identifier><identifier>EISSN: 1460-2156</identifier><identifier>DOI: 10.1093/brain/awl218</identifier><identifier>PMID: 16951410</identifier><identifier>CODEN: BRAIAK</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Action Potentials - physiology ; Adult ; Age Factors ; Anticonvulsants - administration &amp; dosage ; Biological and medical sciences ; Blood-Brain Barrier - physiopathology ; Brain Neoplasms - physiopathology ; Carbamazepine - administration &amp; dosage ; Dentate Gyrus - drug effects ; Drug Administration Schedule ; drug resistance ; Drug Resistance - physiology ; Electric Stimulation - methods ; electrophysiology ; epilepsy ; Epilepsy, Temporal Lobe - drug therapy ; Epilepsy, Temporal Lobe - physiopathology ; Female ; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy ; hippocampus ; human ; Human viral diseases ; Humans ; Infectious diseases ; Male ; Medical sciences ; Nervous system (semeiology, syndromes) ; Neurology ; Potassium - metabolism ; Time Factors ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids</subject><ispartof>Brain (London, England : 1878), 2006-12, Vol.129 (12), p.3290-3306</ispartof><rights>2007 INIST-CNRS</rights><rights>Copyright Oxford University Press(England) Dec 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c453t-d4e14389a3e2960204787bcd5d12640f3664691d9729e03b4ce27652f1657c833</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18360626$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16951410$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jandová, Katerina</creatorcontrib><creatorcontrib>Päsler, Dennis</creatorcontrib><creatorcontrib>Antonio, Leandro Leite</creatorcontrib><creatorcontrib>Raue, Claudia</creatorcontrib><creatorcontrib>Ji, Shengbo</creatorcontrib><creatorcontrib>Njunting, Marleisje</creatorcontrib><creatorcontrib>Kann, Oliver</creatorcontrib><creatorcontrib>Kovács, Richard</creatorcontrib><creatorcontrib>Meencke, Heinz-Joachim</creatorcontrib><creatorcontrib>Cavalheiro, Esper A.</creatorcontrib><creatorcontrib>Heinemann, Uwe</creatorcontrib><creatorcontrib>Gabriel, Siegrun</creatorcontrib><creatorcontrib>Lehmann, Thomas-Nicolas</creatorcontrib><title>Carbamazepine-resistance in the epileptic dentate gyrus of human hippocampal slices</title><title>Brain (London, England : 1878)</title><addtitle>Brain</addtitle><description>Overexpression of drug efflux pumps at the blood brain barrier (BBB) has been suggested to be one important factor contributing to drug resistance in epilepsy. This would imply that resected brain tissue of drug-resistant patients is drug-sensitive in absence of the BBB. Here we studied the effects of carbamazepine (CBZ) at therapeutically relevant concentration on epileptiform activity electrophysiologically recorded in acute hippocampal slices of patients with mesial temporal lobe epilepsy (MTLE; 28 patients, 49 slices) or extra-hippocampal tumours (tumour; 6 patients, 11 slices). Epileptiform activity was induced by hilar stimulation (0.067 Hz) during elevation of extracellular potassium concentration ([K+]o) and remained self-sustained in presence of 10–12 mM [K+]o. Quantitative analysis of data revealed that epileptiform activity in tissue of tumour-patients was predominantly suppressed by CBZ, indicating that the ‘epilepsy model’ used is CBZ-sensitive. In contrast, epileptiform activity in tissue of drug-resistant MTLE patients was resistant to CBZ in 82% of patients, partially suppressed in 11% and completely suppressed in 7%. The effects of CBZ in tissue of MTLE patients did not depend on the type of activity, hippocampal pathology, excitability of the tissue, or equilibration time of the drug. Considering that CBZ has direct access to all compartments of the slice, our results suggest that CBZ-resistance mechanisms are located within the parenchyma of the dentate gyrus and contribute to drug resistance in the majority of MTLE patients. BBB-located drug-resistance mechanisms per se may play a minor role in this region, because CBZ-sensitivity was only observed in 7% of CBZ-resistant patients.</description><subject>Action Potentials - physiology</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Anticonvulsants - administration &amp; dosage</subject><subject>Biological and medical sciences</subject><subject>Blood-Brain Barrier - physiopathology</subject><subject>Brain Neoplasms - physiopathology</subject><subject>Carbamazepine - administration &amp; dosage</subject><subject>Dentate Gyrus - drug effects</subject><subject>Drug Administration Schedule</subject><subject>drug resistance</subject><subject>Drug Resistance - physiology</subject><subject>Electric Stimulation - methods</subject><subject>electrophysiology</subject><subject>epilepsy</subject><subject>Epilepsy, Temporal Lobe - drug therapy</subject><subject>Epilepsy, Temporal Lobe - physiopathology</subject><subject>Female</subject><subject>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</subject><subject>hippocampus</subject><subject>human</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>Potassium - metabolism</subject><subject>Time Factors</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><issn>0006-8950</issn><issn>1460-2156</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqF0ctrFTEUB-AgFntb3bmWINiVY_M8M1mWS2vF-sIHxU3IZM54U-dlMkOtf72p92LBjatA8nFyzvkR8pizF5wZeVxHF4Zjd90JXt0jK66AFYJruE9WjDEoKqPZPjlI6YoxrqSAB2Sfg9FccbYiH9cu1q53v3AKAxYRU0izGzzSMNB5gzTfdzjNwdMGh9nNSL_dxCXRsaWbpXcD3YRpGr3rJ9fR1AWP6SHZa12X8NHuPCSfz04_rc-Li3cvX61PLgqvtJyLRmHupzJOojDABFNlVda-0Q0XoFgrARQY3phSGGSyVh5FCVq0HHTpKykPydG27hTHHwum2fYheew6N-C4JAsVN8CV-C_keUVMQ5nh03_g1bjEIQ9xa5TKv7OMnm-Rj2NKEVs7xdC7eGM5s7eR2D-R2G0kmT_Z1VzqHps7vMsgg2c74JJ3XRvz-kO6c5UEBgKyK7YuJ4Q__767-N3m1kttzy-_Wrgs3795--W1_SB_A1kto2U</recordid><startdate>20061201</startdate><enddate>20061201</enddate><creator>Jandová, Katerina</creator><creator>Päsler, Dennis</creator><creator>Antonio, Leandro Leite</creator><creator>Raue, Claudia</creator><creator>Ji, Shengbo</creator><creator>Njunting, Marleisje</creator><creator>Kann, Oliver</creator><creator>Kovács, Richard</creator><creator>Meencke, Heinz-Joachim</creator><creator>Cavalheiro, Esper A.</creator><creator>Heinemann, Uwe</creator><creator>Gabriel, Siegrun</creator><creator>Lehmann, Thomas-Nicolas</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20061201</creationdate><title>Carbamazepine-resistance in the epileptic dentate gyrus of human hippocampal slices</title><author>Jandová, Katerina ; Päsler, Dennis ; Antonio, Leandro Leite ; Raue, Claudia ; Ji, Shengbo ; Njunting, Marleisje ; Kann, Oliver ; Kovács, Richard ; Meencke, Heinz-Joachim ; Cavalheiro, Esper A. ; Heinemann, Uwe ; Gabriel, Siegrun ; Lehmann, Thomas-Nicolas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c453t-d4e14389a3e2960204787bcd5d12640f3664691d9729e03b4ce27652f1657c833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Action Potentials - physiology</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Anticonvulsants - administration &amp; dosage</topic><topic>Biological and medical sciences</topic><topic>Blood-Brain Barrier - physiopathology</topic><topic>Brain Neoplasms - physiopathology</topic><topic>Carbamazepine - administration &amp; dosage</topic><topic>Dentate Gyrus - drug effects</topic><topic>Drug Administration Schedule</topic><topic>drug resistance</topic><topic>Drug Resistance - physiology</topic><topic>Electric Stimulation - methods</topic><topic>electrophysiology</topic><topic>epilepsy</topic><topic>Epilepsy, Temporal Lobe - drug therapy</topic><topic>Epilepsy, Temporal Lobe - physiopathology</topic><topic>Female</topic><topic>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</topic><topic>hippocampus</topic><topic>human</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>Potassium - metabolism</topic><topic>Time Factors</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jandová, Katerina</creatorcontrib><creatorcontrib>Päsler, Dennis</creatorcontrib><creatorcontrib>Antonio, Leandro Leite</creatorcontrib><creatorcontrib>Raue, Claudia</creatorcontrib><creatorcontrib>Ji, Shengbo</creatorcontrib><creatorcontrib>Njunting, Marleisje</creatorcontrib><creatorcontrib>Kann, Oliver</creatorcontrib><creatorcontrib>Kovács, Richard</creatorcontrib><creatorcontrib>Meencke, Heinz-Joachim</creatorcontrib><creatorcontrib>Cavalheiro, Esper A.</creatorcontrib><creatorcontrib>Heinemann, Uwe</creatorcontrib><creatorcontrib>Gabriel, Siegrun</creatorcontrib><creatorcontrib>Lehmann, Thomas-Nicolas</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Brain (London, England : 1878)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jandová, Katerina</au><au>Päsler, Dennis</au><au>Antonio, Leandro Leite</au><au>Raue, Claudia</au><au>Ji, Shengbo</au><au>Njunting, Marleisje</au><au>Kann, Oliver</au><au>Kovács, Richard</au><au>Meencke, Heinz-Joachim</au><au>Cavalheiro, Esper A.</au><au>Heinemann, Uwe</au><au>Gabriel, Siegrun</au><au>Lehmann, Thomas-Nicolas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Carbamazepine-resistance in the epileptic dentate gyrus of human hippocampal slices</atitle><jtitle>Brain (London, England : 1878)</jtitle><addtitle>Brain</addtitle><date>2006-12-01</date><risdate>2006</risdate><volume>129</volume><issue>12</issue><spage>3290</spage><epage>3306</epage><pages>3290-3306</pages><issn>0006-8950</issn><eissn>1460-2156</eissn><coden>BRAIAK</coden><abstract>Overexpression of drug efflux pumps at the blood brain barrier (BBB) has been suggested to be one important factor contributing to drug resistance in epilepsy. This would imply that resected brain tissue of drug-resistant patients is drug-sensitive in absence of the BBB. Here we studied the effects of carbamazepine (CBZ) at therapeutically relevant concentration on epileptiform activity electrophysiologically recorded in acute hippocampal slices of patients with mesial temporal lobe epilepsy (MTLE; 28 patients, 49 slices) or extra-hippocampal tumours (tumour; 6 patients, 11 slices). Epileptiform activity was induced by hilar stimulation (0.067 Hz) during elevation of extracellular potassium concentration ([K+]o) and remained self-sustained in presence of 10–12 mM [K+]o. Quantitative analysis of data revealed that epileptiform activity in tissue of tumour-patients was predominantly suppressed by CBZ, indicating that the ‘epilepsy model’ used is CBZ-sensitive. In contrast, epileptiform activity in tissue of drug-resistant MTLE patients was resistant to CBZ in 82% of patients, partially suppressed in 11% and completely suppressed in 7%. The effects of CBZ in tissue of MTLE patients did not depend on the type of activity, hippocampal pathology, excitability of the tissue, or equilibration time of the drug. Considering that CBZ has direct access to all compartments of the slice, our results suggest that CBZ-resistance mechanisms are located within the parenchyma of the dentate gyrus and contribute to drug resistance in the majority of MTLE patients. BBB-located drug-resistance mechanisms per se may play a minor role in this region, because CBZ-sensitivity was only observed in 7% of CBZ-resistant patients.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>16951410</pmid><doi>10.1093/brain/awl218</doi><tpages>17</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-8950
ispartof Brain (London, England : 1878), 2006-12, Vol.129 (12), p.3290-3306
issn 0006-8950
1460-2156
language eng
recordid cdi_proquest_miscellaneous_68196142
source Oxford Journals Online
subjects Action Potentials - physiology
Adult
Age Factors
Anticonvulsants - administration & dosage
Biological and medical sciences
Blood-Brain Barrier - physiopathology
Brain Neoplasms - physiopathology
Carbamazepine - administration & dosage
Dentate Gyrus - drug effects
Drug Administration Schedule
drug resistance
Drug Resistance - physiology
Electric Stimulation - methods
electrophysiology
epilepsy
Epilepsy, Temporal Lobe - drug therapy
Epilepsy, Temporal Lobe - physiopathology
Female
Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy
hippocampus
human
Human viral diseases
Humans
Infectious diseases
Male
Medical sciences
Nervous system (semeiology, syndromes)
Neurology
Potassium - metabolism
Time Factors
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
title Carbamazepine-resistance in the epileptic dentate gyrus of human hippocampal slices
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T22%3A14%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Carbamazepine-resistance%20in%20the%20epileptic%20dentate%20gyrus%20of%20human%20hippocampal%20slices&rft.jtitle=Brain%20(London,%20England%20:%201878)&rft.au=Jandov%C3%A1,%20Katerina&rft.date=2006-12-01&rft.volume=129&rft.issue=12&rft.spage=3290&rft.epage=3306&rft.pages=3290-3306&rft.issn=0006-8950&rft.eissn=1460-2156&rft.coden=BRAIAK&rft_id=info:doi/10.1093/brain/awl218&rft_dat=%3Cproquest_cross%3E68196142%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c453t-d4e14389a3e2960204787bcd5d12640f3664691d9729e03b4ce27652f1657c833%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=195446520&rft_id=info:pmid/16951410&rfr_iscdi=true